Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

55.81
Delayed Data
As of 3:59pm ET
 +1.73 / +3.20%
Today’s Change
44.16
Today|||52-Week Range
91.11
-20.50%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
7:03am / TheStreet.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content

Performance

1 month-4.79% 3 years+16.64%
3 months+7.26% 5 years+17.82%
1 year-32.46% Since inception+12.49%
Data through 06/30/2016

Quote Details

Previous close$54.08
Open day’s range53.80 – 55.88
Net asset value (NAV)54.08 (06/29/2016)
Daily volume9,345,540
Average volume (3 months)7,417,908
Data as of 3:59pm ET, 07/01/2016

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+17.82%+15.78%
Expense Gross exp ratio0.35%0.48%
Risk 5 year sharpe ratio0.730.98
Net assets$1.9B$1.2B
Average market cap$3.8B$36.0B
Average P/E--24.4
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ACAD ACADIA Pharmaceuticals Inc3.03%
-- 2.70%
MDVN Medivation Inc2.68%
ALKS Alkermes Plc2.43%
NBIX Neurocrine Biosciences Inc2.42%
ICPT Intercept Pharmaceuticals Inc2.18%
NVAX Novavax Inc2.15%
RARE Ultragenyx Pharmaceutical Inc2.10%
SGEN Seattle Genetics Inc2.09%
INCY Incyte Corp2.05%

Partner Offers